Aethlon Medical Inc
NASDAQ:AEMD

  • LAST PRICE
    0.4178
  • TODAY'S CHANGE (%)
    0.0178 (4.4500%)
  • Bid / Lots
    0.4118/ 1
  • Ask / Lots
    0.4238/ 4
  • Open / Previous Close
    0.4200 / 0.4000
  • Day Range
    0.4118
    0.4238
  • 52 Week Range
    0.3704
    5.0000
  • Volume
    57,924

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 15, 2024

      Show headlines and story abstract

    • 1:34PM ET on Wednesday May 15, 2024 by MT Newswires
      Companies Mentioned: AEMD, YTEN, BOLT
      01:34 PM EDT, 05/15/2024 (MT Newswires) -- Yield10 Bioscience (YTEN) said Wednesday it received a final delisting notice from Nasdaq after failing to regain compliance with the exchange's listing rule that requires listed firms to maintain stockhold...

    • 9:15AM ET on Wednesday May 15, 2024 by PR Newswire
      Companies Mentioned: AEMD

      Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an aggregate of 8,100,000 shares of its common stock (or pre-funded warrants in lieu thereof), Class A warrants to purchase up to 8,100,000 shares of common stock, and Class B warrants to purchase up to 8,100,000 shares of common stock, at a combined public offering price of $0.58 per share (or pre-funded warrant) and accompanying warrants. The warrants will have an exercise price of $0.58 per share, subject to an adjustment, will be exercisable immediately upon issuance and, in the case of Class A warrants, will expire on the fifth anniversary of the original issuance date, and in the case of Class B warrants, will expire on the one year anniversary of the original issuance date. The closing of the offering is expected to occur on or about May 17, 2024, subject to the satisfaction of customary closing conditions.

    • 9:15AM ET on Wednesday May 15, 2024 by Dow Jones
      Companies Mentioned: AEMD

      Aethlon Medical Announces Pricing of $4.7 Million Public Offering

      PR Newswire

      SAN DIEGO, May 15, 2024

      SAN DIEGO, May 15, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an aggregate of 8,100,000 shares of its common stock (or pre-funded warrants in lieu thereof), Class A warrants to purchase up to 8,100,000 shares of common stock, and Class B warrants to purchase up to 8,100,000 shares of common stock, at a combined public offering price of $0.58 per share (or pre-funded warrant) and accompanying warrants. The warrants will have an exercise price of $0.58 per share, subject to an adjustment, will be exercisable immediately upon issuance and, in the case of Class A warrants, will expire on the fifth anniversary of the original issuance date, and in the case of Class B warrants, will expire on the one year anniversary of the original issuance date. The closing of the offering is expected to occur on or about May 17, 2024, subject to the satisfaction of customary closing conditions.

  • May 13, 2024

Peers Headlines